FDA Adverse Event Malfunction Summary report: N

COBAS 600 C501MODULE

MDR report key: 1105141 · Received August 8, 2008

Report

Report Number
1823260-2008-06060
Event Type
Malfunction
Date Received
August 8, 2008
Date of Event
July 15, 2008
Report Date
August 8, 2008
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CEM
PMA / PMN Number
K060373
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NH, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Description of Event or Problem · 1

THE FOLLOWING DISCREPANT RESULTS WERE GENERATED AS PART OF CORRELATION STUDIES FOR IGG, VANCOMYCIN, AND CARBAMAZEPINE. IGG INITIAL AND REPEAT RESULTS IN MG/DL. SAMPLE 1: 1021, 764; SAMPLE 2: 2418, 1929. VANCOMYCIN INITIAL AND REPEAT RESULTS IN UG/ML. SAMPLE 1: 35.2, 28.1. SAMPLE 2: 38.2, 31.3. SAMPLE 3: 11.8, 9.0. SAMPLE 4: 9.1, 7.1. SAMPLE 5: 10.8, 8.6. SAMPLE 6: 7.4, 5.2. SAMPLE 7: 9.1,6.7. SAMPLE 8: 6.5, 5.4. SAMPLE 9: 9.9, 7.0. SAMPLE 10: 6.7, 4.6. SAMPLE 11: 4.5, 3.7. SAMPLE 12: 11.5, 9.3. CARBAMAZEPINE INITIAL AND REPEAT RESULTS IN UG/ML. SAMPLE 1: 8.5, 6.73. SAMPLE 2: 11.0, 8.62. SAMPLE 3: 8.4, 6.49. SAMPLE 4: 12.4, 9.64. SAMPLE 5: 11.6, 9.22. SAMPLE 6: 11.4, 8.91. RESULTS GENERATED DURING THIS STUDY WERE USED FOR STUDY PURPOSES ONLY. IF ADDITIONAL INFO IS RECEIVED, APPROPRIATE NOTIFICATION WILL BE PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COBAS 600 C501MODULE CLINICAL CHEMISTRY ANALYZER- CEM CEM ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 UNK